MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature

  • Mohd Imran
  • , Mandeep Kumar Arora
  • , Anurag Chaudhary
  • , Shah Alam Khan
  • , Mehnaz Kamal
  • , Manal Mutlaq Alshammari
  • , Raghad Mohammad Alharbi
  • , Nuha Abdullah Althomali
  • , Ibrahim Mohammed Alzimam
  • , Abdullah Ayed Alshammari
  • , Bashair Hamed Alharbi
  • , Amer Alshengeti
  • , Abdulmonem A. Alsaleh
  • , Shayea A. Alqahtani
  • , Ali A. Rabaan

Research output: Contribution to journal › Review article › peer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science